Table 2.
Associations with mortality.
| Survived | Mortality | ||
|---|---|---|---|
| Age | 60 (9; 126) | 37 (2.75; 138) | 0.63 |
| Comorbidities | 8 (21.6%) | 7 (70%) | 0.007 |
| Vasoactive med. | 14 (37.8%) | 5 (50%) | 0.72 |
| COVID-19 directed therapy | 9 (24.3%) | 5 (50%) | 0.14 |
| Steroids | 21 (56.8%) | 7 (70%) | 0.72 |
| Stroke | 2 (5.4%) | 4 (40%) | 0.014 |
| Admission, referral | 24 (64.9%) | 7 (70%) | 1 |
| Out-of-city transfer | 5 (13.5%) | 2 (20%) | 0.63 |
| PaO2/FiO2 < 100 | 4 (22.2%) | 4 (50%) | 0.2 |
| WBC × 103 | 13 (9; 16) | 21 (14; 31) | 0.01 |
| CRP | 33.7 (14.1; 226) | 32.6 (5.1; 274) | 0.98 |
| Platelets | 234 (142; 509) | 147 (54; 369) | 0.12 |
Continuous variables expressed in median and interquartile ranges in parenthesis. Analysis: continuous variables Mann–Whitney U test; categorical Fisher’s exact test. med. medications, WBC white blood cell count, CRP C-reactive protein (mg/L).